157 related articles for article (PubMed ID: 38099640)
1. Active Gα
Lyu C; Bhimani AK; Draus WT; Weigel R; Chen S
Mol Cell Biol; 2023; 43(12):650-663. PubMed ID: 38099640
[TBL] [Abstract][Full Text] [Related]
2. Active Gαi/o mutants accelerate breast tumor metastasis via the c-Src pathway.
Lyu C; Bhimani AK; Draus WT; Weigel R; Chen S
bioRxiv; 2023 Jan; ():. PubMed ID: 36711612
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
[TBL] [Abstract][Full Text] [Related]
4. Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.
Lyu C; Ye Y; Lensing MM; Wagner KU; Weigel RJ; Chen S
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34343132
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract][Full Text] [Related]
6. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo.
Kumbrink J; de la Cueva A; Soni S; Sailer N; Kirsch KH
Tumour Biol; 2016 Aug; 37(8):10665-73. PubMed ID: 26867768
[TBL] [Abstract][Full Text] [Related]
7. A novel role for ezrin in breast cancer angio/lymphangiogenesis.
Ghaffari A; Hoskin V; Szeto A; Hum M; Liaghati N; Nakatsu K; LeBrun D; Madarnas Y; Sengupta S; Elliott BE
Breast Cancer Res; 2014 Sep; 16(5):438. PubMed ID: 25231728
[TBL] [Abstract][Full Text] [Related]
8. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
[TBL] [Abstract][Full Text] [Related]
9. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
10. A critical role of Gbetagamma in tumorigenesis and metastasis of breast cancer.
Tang X; Sun Z; Runne C; Madsen J; Domann F; Henry M; Lin F; Chen S
J Biol Chem; 2011 Apr; 286(15):13244-54. PubMed ID: 21349837
[TBL] [Abstract][Full Text] [Related]
11. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.
Wang S; Yuan Y; Liao L; Kuang SQ; Tien JC; O'Malley BW; Xu J
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):151-6. PubMed ID: 19109434
[TBL] [Abstract][Full Text] [Related]
13. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
15. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.
Tang X; Jin R; Qu G; Wang X; Li Z; Yuan Z; Zhao C; Siwko S; Shi T; Wang P; Xiao J; Liu M; Luo J
Cancer Res; 2013 Oct; 73(20):6206-18. PubMed ID: 24008316
[TBL] [Abstract][Full Text] [Related]
16. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
17. Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Biochim Biophys Acta; 2011 Oct; 1813(10):1767-76. PubMed ID: 21741415
[TBL] [Abstract][Full Text] [Related]
18. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
[TBL] [Abstract][Full Text] [Related]
19. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional signature induced by a metastasis-promoting c-Src mutant in a human breast cell line.
Broecker F; Hardt C; Herwig R; Timmermann B; Kerick M; Wunderlich A; Schweiger MR; Borsig L; Heikenwalder M; Lehrach H; Moelling K
FEBS J; 2016 May; 283(9):1669-88. PubMed ID: 26919036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
